A detailed history of Advisor Group Holdings, Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 859 shares of RXST stock, worth $38,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
859
Previous 804 6.84%
Holding current value
$38,508
Previous $48,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.78 - $57.04 $2,242 - $3,137
55 Added 6.84%
859 $42,000
Q2 2024

Aug 13, 2024

BUY
$50.42 - $64.29 $1,008 - $1,285
20 Added 2.55%
804 $48,000
Q1 2024

May 10, 2024

BUY
$35.51 - $57.92 $17,648 - $28,786
497 Added 173.17%
784 $40,000
Q4 2023

Feb 12, 2024

SELL
$20.91 - $40.9 $16,623 - $32,515
-795 Reduced 73.48%
287 $11,000
Q3 2023

Nov 13, 2023

BUY
$27.05 - $33.37 $17,447 - $21,523
645 Added 147.6%
1,082 $30,000
Q2 2023

Aug 10, 2023

BUY
$16.37 - $28.9 $7,153 - $12,629
437 New
437 $12,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.